Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126205271 | 12620527 | 1 | I | 20160801 | 20160804 | 20160804 | PER | PHEH2016US019213 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160804 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126205271 | 12620527 | 1 | PS | FEMARA | LETROZOLE | 1 | Unknown | 2.5 MG, QD | U | 20726 | 2.5 | MG | QD | ||||||
126205271 | 12620527 | 2 | C | TAXOTERE | DOCETAXEL | 1 | Unknown | U | 0 | ||||||||||
126205271 | 12620527 | 3 | C | TAXOL | PACLITAXEL | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126205271 | 12620527 | 1 | Breast cancer |
126205271 | 12620527 | 2 | Breast cancer |
126205271 | 12620527 | 3 | Breast cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126205271 | 12620527 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126205271 | 12620527 | Breast cancer | |
126205271 | 12620527 | Malignant neoplasm progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |